Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page’s footer revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor site/version update without changing the study details.
    Difference
    0.1%
    Check dated 2026-04-24T17:07:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:42:36.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Updated study timeline: primary completion listed as 2026-06 and study completion as 2026-09. Last update posted on 2026-04-02.
    Difference
    0.3%
    Check dated 2026-04-03T05:14:51.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed as part of a version update. This appears to be a backend or UI update with no changes to the study information displayed on the page.
    Difference
    0.1%
    Check dated 2026-03-19T19:09:15.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T15:00:44.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Added primary peritoneal carcinoma and fallopian tube cancer to the listed conditions, and introduced the Genetic and Rare Diseases Information Center as a new resource. Updated page revision to v3.4.2 and removed the prior funding-status notice (v3.4.1).
    Difference
    0.6%
    Check dated 2026-02-11T21:07:02.000Z thumbnail image

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.